Patents Assigned to Keio University
-
Patent number: 11220418Abstract: Weighing and filling apparatus for controlling filling device based on a container weight. A linear actuator for driving a drive shaft coupled to container support unit is included, a weight measuring unit determines the container weight from a detected height of the drive shaft detected by a height detecting unit and a drive signal of the linear actuator at the detected height. A first acceleration signal is calculated from a specified height of the container support unit set in advance and the height detected by the height detecting unit, a second acceleration signal is calculated from the container weight and an expected weight expected to be applied to the container support unit. The container support unit is kept at the specified height by a drive signal calculated from the first and second acceleration signals.Type: GrantFiled: April 17, 2019Date of Patent: January 11, 2022Assignees: KEIO UNIVERSITY, SHIBUYA CORPORATIONInventors: Takahiro Nozaki, Kouhei Ohnishi, Toshiaki Naka, Masato Ohta, Takaharu Kikura
-
Publication number: 20210404009Abstract: A method for determining a risk of urothelial carcinoma may be based on the methylation level of DNA. A method for determining a risk of canceration of a urothelial tissue may involve detecting the DNA methylation level of a CpG site of at least one gene selected from TENM3, HOXC4, TLR1, CPVL and PRDM16 in genomic DNA preferably derived from a urothelial cell or a tissue containing the urothelial cell; and determining a risk of canceration of the urothelial tissue from the detected DNA methylation level.Type: ApplicationFiled: March 19, 2019Publication date: December 30, 2021Applicant: KEIO UNIVERSITYInventors: Yae KANAI, Eri ARAI
-
Publication number: 20210393634Abstract: The present invention provides a prophylactic and/or therapeutic agent for inflammatory disease including a compound or a salt thereof, or a solvate thereof, the compound represented by a formula (1): [where each sign is defined as described in the description] as an active ingredient.Type: ApplicationFiled: May 10, 2019Publication date: December 23, 2021Applicant: KEIO UNIVERSITYInventors: Tsutomu Takeuchi, Katsuya Suzuki, Keiko Yoshimoto
-
Publication number: 20210395692Abstract: In related-art methods of differentiating pluripotent stem cells into a desired cell type, there has not been established a differentiation induction method using human ES/iPS cells and being stable and highly efficient. A method of inducing differentiation into a desired cell type within a short period of time and with high efficiency by attenuating differentiation resistance of a pluripotent stem cell to generate a pluripotent stem cell that actively proceeds to a differentiated cell type has been found, and thus the present invention has been completed.Type: ApplicationFiled: September 3, 2021Publication date: December 23, 2021Applicant: KEIO UNIVERSITYInventors: Minoru Ko, Tomohiko Akiyama
-
Patent number: 11193107Abstract: The invention provides a method for producing a substrate for supporting cells, including a humidification step of humidifying the periphery of a non-fluorine resin based substrate, and a UV irradiation step of irradiating the substrate with UV in an oxygen and/or ozone containing atmosphere during and/or after the humidification step. The invention also provides a substrate for supporting cells, which is a non-fluorine resin based substrate. The substrate has a cell supporting surface for supporting cells, containing a component capable of generating C7H5O+ molecules by beam irradiation of a time-of-flight secondary ion mass spectrometer, such that cells are supported on the cell-supporting surface.Type: GrantFiled: February 24, 2016Date of Patent: December 7, 2021Assignees: Ebara Jitsugyo Co., Ltd., Keio UniversityInventors: Shuichi Takahashi, Michio Ohira, Hideo Nakata, Shogo Miyata, Shugo Tohyama, Jun Fujita, Keiichi Fukuda
-
Publication number: 20210369785Abstract: A cell preparation for treating brain tumors used in combination with a prodrug that is converted to 5-fluorouracil by cytosine deaminase, wherein the cell preparation comprises neural stem cells derived from pluripotent stem cells having a cytosine deaminase gene and a uracil phosphoribosyltransferase gene is provided to establish new means for treating brain tumors.Type: ApplicationFiled: November 19, 2018Publication date: December 2, 2021Applicant: KEIO UNIVERSITYInventors: Masahiro TODA, Hideyuki OKANO, Hiroyuki MIYOSHI, Ryota TAMURA
-
Patent number: 11167018Abstract: Provided herein are compositions and methods for the induction and/or proliferation of CD8+ T-cells. The disclosure also provides methods of treatment of diseases that can be treated by the induction and/or proliferation of CD8+ T-cells.Type: GrantFiled: December 22, 2017Date of Patent: November 9, 2021Assignees: Keio University, The University of TokyoInventors: Kenya Honda, Takeshi Tanoue, Masahira Hattori, Yutaka Kawakami
-
Publication number: 20210334336Abstract: A function generation apparatus includes a function setter, a data string selector, and a matrix generator. The function setter sets a target function in an apparatus to be controlled. The data string selector selects, from among data strings indicating a plurality of combinations of parameters that can be reflected in control in the apparatus to be controlled, data strings according to the function set by the function setter. The matrix generator generates a transformation matrix according to the target function using the data strings selected by the data string selector as elements.Type: ApplicationFiled: September 2, 2019Publication date: October 28, 2021Applicants: KEIO UNIVERSITY, Motion Lib, Inc.Inventors: Kouhei OHNISHI, Takahiro MIZOGUCHI
-
Patent number: 11147248Abstract: A method for producing a new deafness model animal and a new deafness model animal produced by the method, enabling research that can also be applied to clinical application to a human. The present invention provides a method for producing an acoustic trauma deafness model animal, the method including exposing a non-human primate animal to a sound having a frequency of 1 kHz to 32 kHz and a sound pressure level of 100 dB to 150 dB for 10 minutes to 360 minutes. In addition, the present invention provides an acoustic trauma deafness model animal provided by the method for producing an acoustic trauma deafness model animal.Type: GrantFiled: November 21, 2018Date of Patent: October 19, 2021Assignees: KEIO UNIVERSITY, THE JIKEI UNIVERSITY SCHOOL OF MEDICINEInventors: Masato Fujioka, Hirotaka James Okano, Hiromi Kojima, Sho Kurihara, Tomohiko Yoshida
-
Patent number: 11136552Abstract: In related-art methods of differentiating pluripotent stem cells into a desired cell type, there has not been established a differentiation induction method using human ES/iPS cells and being stable and highly efficient. A method of inducing differentiation into a desired cell type within a short period of time and with high efficiency by attenuating differentiation resistance of a pluripotent stem cell to generate a pluripotent stem cell that actively proceeds to a differentiated cell type has been found, and thus the present invention has been completed.Type: GrantFiled: October 28, 2016Date of Patent: October 5, 2021Assignee: KEIO UNIVERSITYInventors: Minoru Ko, Tomohiko Akiyama
-
Publication number: 20210302444Abstract: Disclosed is a method for measuring a blood coagulation activity, comprising: acquiring a parameter related to differentiation of a coagulation waveform in a blood specimen collected from a patient administered with (1) a polypeptide containing a sequence represented by SEQ ID NO: 1, or (2) a polypeptide containing a polypeptide having 95% or more identity with the sequence represented by SEQ ID NO: 1 and having an activity as a blood coagulation factor VIII; and acquiring an activity value of a blood coagulation factor VIII in the blood specimen based on the acquired parameter.Type: ApplicationFiled: March 24, 2021Publication date: September 30, 2021Applicants: SYSMEX CORPORATION, KEIO UNIVERSITY, SOCIAL WELFARE ORGANIZATION SAISEIKAI IMPERIAL GIFT FOUNDATION, INC.Inventors: Sho SHINOHARA, Osamu KUMANO, Nobuo ARAI, Seiji MADOIWA, Yuta FUJIMORI
-
Patent number: 11122964Abstract: A treatment-instrument insertion aid (10) for aiding insertion of a treatment-instrument into a body includes an outer tube (30) having flexibility including a plurality of guiding portions (31) circumferentially spaced apart on an inner peripheral surface and extend in an axial direction from a distal end to a proximal end, a plurality of rail members (40) having flexibility, extend in an axial direction from a distal end to a proximal end and include guided portions (41) to be engaged with the guiding portions (31) respectively, and an inner tube (20) having flexibility and includes an engaged portion (21) to be engaged with an engaging portion (50) formed between the inner peripheral surface of the outer tube (30) and the adjacent rail members (40). The rail members (40) are fixed to a hard portion (30B) nearest to the distal end side of the outer tube (30).Type: GrantFiled: March 12, 2015Date of Patent: September 21, 2021Assignees: KEIO UNIVERSITY, KABUSHIKI KAISHA TOPInventors: Norihito Wada, Takuya Miyazaki, Yoshihiko Himura
-
Patent number: 11125925Abstract: To provide a volume-type optical element in which a self-cloning photonic crystal is used. An optical element is provided with half-wave plates of photonic crystals formed on the xy plane and laminated in the z-axis direction in a three-dimensional space x, y, z. The groove direction of the photonic crystals is a curved line, and the angle in relation to the y-axis direction changes continuously in the range of 0°-180°. Light entering the optical element in the axial direction is emitted from the optical element upon being divided and converted into clockwise circularly polarized light in the direction facing the x-axis by a given angle from the z-axis and anticlockwise circularly polarized light in the direction facing the ?x-axis by a given angle from the z-axis. Laminating or placing a quarter-wave plate comprising a photonic crystal on one or both surfaces makes it possible to divide light entering from the z-axis direction of the optical element into two orthogonal linearly polarized lights.Type: GrantFiled: February 28, 2017Date of Patent: September 21, 2021Assignees: Photonic Lattice, Inc., Sophia School Corporation, Keio UniversityInventors: Shojiro Kawakami, Takayuki Kawashima, Takafumi Chiba, Toshikazu Ijiro, Hiroyuki Tsuda, Hiroshi Takahashi
-
Publication number: 20210282795Abstract: A medical gripping device includes a housing, a gripping mechanism at one end of the housing, an operation unit, and a reaction force actuator and a gripping actuator installed in the housing. The operation unit is operated by a gripping operation of an operator, and the reaction force actuator applies an operation reaction force to the operation unit. The gripping actuator causes the gripping mechanism to perform a gripping operation. A control unit controls a force and a position that are output by the gripping actuator in an operation of the gripping mechanism in accordance with an operation with respect to the operation unit, and controls a force and a position that are output by the reaction force actuator in an operation of applying the operation reaction force to the operation unit in accordance with a reaction from a gripped object with respect to the gripping mechanism.Type: ApplicationFiled: June 7, 2019Publication date: September 16, 2021Applicants: KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY, KEIO UNIVERSITYInventors: Tomoyuki SHIMONO, Hikaru SASAKI, Kouhei OHNISHI, Shunsuke SHIBAO, Takahiro MIZOGUCHI, Takuya MATSUNAGA, Eriko ABIKO, Masaaki NISHIMOTO, Mika AOKI
-
Patent number: 11108449Abstract: A radio communication apparatus is described that includes a reception antenna, a converter, a calculator, and a separator. The reception antenna receives a mixed signal including two or more backscatter signals respectively transmitted from two or more tag devices and the converter converts the mixed signal into complex data on a complex plane. The calculator calculates phase angles of carrier waves of the two or more backscatter signals to approximate the phase angles into a complex data sequence of a predetermined length, and generates a projector matrix formed of a combination of the phase angles of carrier waves of the two or more backscatter signals. The separator separates the two or more backscatter signals from the mixed signal based on an inverse matrix of the projector matrix and the complex data sequence.Type: GrantFiled: December 27, 2019Date of Patent: August 31, 2021Assignees: KEIO UNIVERSITY, SCHOOL JUDICIAL PERSON IKUTOKUGAKUEN, KYOWA ELECTRONIC INSTRUMENTS CO., LTDInventors: Jin Mitsugi, Haruhisa Ichikawa, Yuusuke Kawakita, Kiyoshi Egawa
-
Publication number: 20210239552Abstract: A data generation device includes: a parameter generator; and a reaction force data generator. The parameter generator generates value data based on a signal having a correlation with a driving force. The parameter generator generates velocity data based on a signal representing a response of a member driven by the driving force. The reaction force data generator generates data of a reaction force received by the member from a predetermined object based on the value data and the velocity data.Type: ApplicationFiled: May 7, 2019Publication date: August 5, 2021Applicants: Yokogawa Electric Corporation, KEIO UNIVERSITYInventors: Yuki SAITO, Kouhei OHNISHI, Takahiro NOZAKI
-
Publication number: 20210228307Abstract: A monitor is arranged on the opposite side of a surgery table to a main doctor so that an assistant is able to view a surgery area directly without being blocked by the monitor. A camera has a working distance of more than or equal to 60 cm and is therefore above a view field for the main doctor to view the monitor, so that the visibility of the monitor is not hindered. The working distance is not more than 100 cm so that the resolution of the camera is not lowered too much.Type: ApplicationFiled: May 23, 2019Publication date: July 29, 2021Applicants: Keio University, Mitaka Kohki Co., Ltd.Inventors: Eiji KOBAYASHI, Shinji UEMOTO, Shintaro YAGI, Katsuyuki NAKAMURA
-
Patent number: 11073586Abstract: A magnetic resonance imaging method according to an embodiment includes performing a balanced SSFP sequence, repeatedly applies an excitation RF pulse to a subject at intervals of a repetition time and applies gradient magnetic field pulses balanced such that a time integral becomes zero within each interval of the repetition time, while further applying a spin labeling gradient magnetic field for generating one or more continuous spin labels within each interval of the repetition time.Type: GrantFiled: November 29, 2019Date of Patent: July 27, 2021Assignees: Keio University, CANON MEDICAL SYSTEMS CORPORATIONInventors: Koichi Oshio, Shinya Yamada, Masao Yui, Seiko Sakuraba
-
Publication number: 20210213163Abstract: Provided is a bone-regeneration material comprising biodegradable fibers and exhibiting antimicrobial properties at an early stage following surgery, A method for producing a bone-regeneration material having antimicrobial properties and comprising biodegradable fibers, wherein the bone-regeneration material is produced by a step in which the biodegradable fibers are immersed in an inositol phosphate solution, then subsequently immersed in a solution containing silver ions, the biodegradable fibers have an outer diameter of 10-100 ?m, contain at least 30 wt % or more of a biodegradable resin and 40 wt % or more of calcium compound particles, and some of the calcium compound particles are exposed on the surface of the biodegradable fibers.Type: ApplicationFiled: May 15, 2019Publication date: July 15, 2021Applicants: Meiji University, Nagoya Institute of Technology, Keio University, ORTHOREBIRTH CO. LTD.Inventors: Mamoru AIZAWA, Michiyo HONDA, Tomohiro YOKOTA, Kodai ABE, Mayu UEDA, Toshihiro KASUGA, Ken ISHII, Morio MATSUMOTO, Masashi MAKITA
-
Patent number: 11058669Abstract: An object of the present invention is to provide novel apoptosis inhibitors and therapeutic agents for inner ear hearing impairment. As a pharmaceutical agent for this purpose, biguanide compounds represented by the following structural formula (I) or a rapamycin derivative represented by the following structural formula (II) as an active ingredient is provided: wherein R1 to R7 are each independently selected from a hydrogen atom, a halogen atom, or a C1-6 alkyl group, a C3-8 cycloalkyl group, a C6-10 aryl group, a 5- or 6-membered heteroaryl group, or a 5- or 6-membered non-aromatic heterocyclic group, each of which may have a substituent selected from a halogen atom, a cyano group, a C1-6 alkyl group, a C1-6 alkoxy group, a C1-6 alkoxy carbonyl group, a C3-8 cycloalkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, and a phenyl group; wherein R1 is a C1-6 alkyl or a C3-6 alkynyl, R2 is H, —CH2-OH or —CH2—CH2OH, and X is ?O, (H, H) or (H, OH).Type: GrantFiled: January 13, 2016Date of Patent: July 13, 2021Assignee: Keio UniversityInventors: Makoto Hosoya, Masato Fujioka, Hideyuki Okano, Kaoru Ogawa, Tatsuo Matsunaga